Authors
Loading...
Randomized trial shows gabapentin and solifenacin enhance symptom control in patients with ureteral stents, indicating better health outcomes.
Soltani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: